153 results
Page 2 of 8
8-K
EX-99.1
4orwmi7afnopm
12 Apr 23
Regulation FD Disclosure
8:45am
D
ve2jtc1bu8bvu
30 Aug 22
$7.41M in options / securities to be acquired, 8 investors
8:00am
8-K
EX-99.1
r8nh84a7vnv4e0
21 Jun 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
jbvzvjuu7 dwkj
23 Feb 22
Regulation FD Disclosure
12:02pm
8-K
EX-99.1
o6olg 6rm8fzxwq6myp
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am
8-K
EX-99.1
c495gbwg37othni
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am
8-K
EX-99.1
f83e83
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm